Selected Grants
North Carolina Clinical Center for the Eunice Kennedy Shiver NICHD Cooperative Multicenter Neonatal Research Network
ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2001 - 2030BPCA Innovative Trial Designs and Assay Developments in Pediatric Therapeutics
ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2026BPCA Concept Development, Investigator Development and Clinical Trial Readiness Support (Version 2.0) - Option Period 1
ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2025Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and Young Children (COA APTIC)
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2023 - 2025Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and your Children (COA APTIC)
ResearchSite PI · Awarded by Food and Drug Administration · 2019 - 2025Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
ResearchPharmacist · Awarded by National Institutes of Health · 2019 - 2025PTN Task Order 8 COVID-19 Studies
Clinical TrialCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2025PTN 2.0 TO 6 Down Syndrome Extension
ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025PTN 2.0: Task order #2 COVID-19 POP02
Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2025PTN TO: BPCA INNOVATIVE TRIAL DESIGNS FOR DOSING, SAFETY, and EFFICACY in PEDIATRIC THERAPEUTICS
Clinical TrialCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025MERCK: Palivizumab (MK 1654)
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme LLC. · 2022 - 2024Pharmacokinetics and Safety of Anesthetics and Analgesics in Children
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2023PTN2- TO# BPCA Pharmacology Studies
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2023A Phase 1b, Multicenter, double blind randomized controlled dose escalating trial of fentanyl vs. fentanyl + dexmedetomidine as the initial regimen for maintenance of sedation in mechanically-ventilated, critically ill children
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2023PTN 2.0- TO 3 - Option 3 - BPCA Concept Development and Clinical Trial Readiness Support
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2021 - 2022Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POPS)
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2020 - 2022Pharmacokinetics and Safety Profile of Digoxin in Infants with Single Ventricle Congenital Heart Disease
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2019 - 20227586 POPS I (Task Order 2) - DUK99
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2018 - 2022Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2018 - 2022Clinical Pharmacokinetics and Safety Trials in Down Syndrome
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2022An open-label study to evaluate the single-dose pharmacokinetics and safety of ceftobiprole in neonate and infant subjects aged up to 3 months undergoing treatment with systemic antibiotics
Clinical TrialPrincipal Investigator · Awarded by Basilea Pharmaceutica · 2018 - 2021POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION INITIATIVE (Phase 1)
ResearchCo Investigator · Awarded by New York University School of Medicine · 2021 - 2021PTN2- TO# 3 Concept Development and Clinical Trial Readiness Support Option Period 1
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2019 - 2020Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2020Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2020Pharmacokinetics of ant-epileptic Drugs in Obese Children (HHSN-275201000003I)
Clinical TrialPrincipal Investigator · Awarded by Duke Clinical Research Institute · 2016 - 2020DUKE POP V (DUKE 10)- TO 49
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2020POP V (Duke 08) TO 49
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2020NICHD-2017-ABS02 Long-Term Outcomes Protocol of Premature Infants Enrolled in the NICHD-2013-ABS01 (SCAMP) Study
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2018A Phase 2/3 Randomized, Openn-Label, Multi-center Study to Determine the Safety and Efficacy of Solithromycin in Adolescents (12 to17 years of age, inclusive) and Children (>- 2 months to < 12 years of age) with Suspected or Confirmed Community
Clinical TrialPrincipal Investigator · Awarded by Duke Clinical Research Institute · 2017 - 2018POPS III -Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care (HHSN-275201000003I)
Clinical TrialPrincipal Investigator · Awarded by Duke Clinical Research Institute · 2016 - 2018POPS IV - (HHSN-275201000003I) PTN Opportunity 14- Task Order 43
Clinical TrialPrincipal Investigator · Awarded by Duke Clinical Research Institute · 2016 - 2018Molecular Basis of Postoperative Delirium in the Elderly
ResearchPharmacist · Awarded by National Institutes of Health · 2003 - 2010External Relationships
- Fresenius-Kabi
- Merck
- Tellus Therapeutics, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.